| Today's Top Story |  |  | | - Analysis: Biotech investors wary, despite product launches
Investors are being more cautious about biotech stocks after initial sales of high-profile new products fell short of analysts' high expectations. The uncertainty is driving some biotech companies to avoid high-profile product launches and pursue opportunities in niche markets. "There was a time when products got full value prior to launch. I think we have now swung back in the other direction," said Affymax CEO John Orwin. Reuters (1/13)        |  |  | | How to turn money you already spend into points you can use:
Introducing The New Business Gold Rewards Card from American Express OPEN, designed to earn Membership Rewards® points faster: 3X on airfare. 2X on advertising, gas & shipping. 1X on everything else. Use points to pay for travel, Amazon.com purchases, Facebook ads, and more.
LEARN MORE & APPLY | |  |  |  |
  - MediciNova licenses drug from CU-Boulder
University of Colorado-Boulder granted MediciNova the licensing rights to ibudilast, a candidate for the treatment of anxiety in patients with traumatic brain injuries. Administration of ibudilast for more than a month after concussion reversed anxiety in rats for a three-month period after therapy. The deal's terms were not released. Boulder County Business Report (Colo.) (1/16) - Lab grows three types of blood vessel cells
British researchers have used patient skin cells to grow the three main cell types that compose blood vessels, according to a report in the journal Nature Biotechnology. The production of vessels in the lab could lead to alternatives to heart bypass and stenting. The cells "could be used to build an artificial artery in a test tube or the stem cells could be injected straight into the heart and they could form within it," the lead researcher said. The Daily Mail (London) (1/16) - Stem cells help new myelin form, mice study finds
When mice with myelin sheath damage, the same problem in people with multiple sclerosis, were injected with stem cells from younger, healthy mice, macrophages cleared away the debris around the myelin sheaths that prevents regeneration, a University of Cambridge study found. New Scientist (1/14)  | Beyond Turbidity: In Situ Monitoring and Control of Complex Particle and Droplet Systems — This whitepaper explains the options available for real-time in-process monitoring and control of suspensions and emulsions and provides guidelines for selecting the right technology for the work being performed. Download the whitepaper. |
 - South Korean biopharma secures $2.6M
The Korea Seoul Life Science Fund has invested $2.6 million through a private placement with CrystalGenomics. Proceeds will support the company's research and development pipeline, including NSAID candidate CG100649, antibacterial drug candidate CG400549, and HDAC inhibitor CG200745, which are in clinical development. Genetic Engineering & Biotechnology News (1/13)  | The 2012 Email Evolution Conference
February 22-24, 2012 | Westin Diplomat Resort & Spa, Hollywood, FL
For everything email and more, EEC12 is where it’s at. This tried-and-true event focuses on the best ways to capitalize on the high ROI this low-cost communication tool can provide both on its own, and integrated with social, search, mobile, video and other email enhancers. Register now for early bird savings! |
 | Global Developments | | | | - CNBG, Aeras work on vaccine against TB
China National Biotech Group and U.S.-based nonprofit tuberculosis institute Aeras are collaborating to develop a TB vaccine they hope could fight even drug-resistant strains. The partnership covers vaccine design, preclinical research, clinical studies, manufacture and sales. Reuters (1/17)
| Food & Agriculture | | | | | Industrial & Environmental | | | | - Vilsack outlines U.S. plan to support production of aviation biofuels
Federal programs will "help buy down the cost" of building the infrastructure for renewable jet fuel production, according to Agriculture Secretary Tom Vilsack. A healthy biofuel industry will help generate jobs in rural America, boost energy independence and curb greenhouse-gas emissions, Vilsack said. "The beauty of this is that it stimulates what America does best: innovation," said Vilsack during a roundtable discussion at Boeing headquarters in Chicago. Chicago Tribune (1/17) | News from BIO | | | | - Are you taking full advantage of your membership?
BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here.
| SmartQuote | | | |  | Experience is a good teacher, but she sends in terrific bills."
--Minna Antrim,
American writer  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Monday, January 16, 2012
- Friday, January 13, 2012
- Thursday, January 12, 2012
- Wednesday, January 11, 2012
- Tuesday, January 10, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment